| GC18335-500μg |
|
55879-47-5 |
|
0 |
C22H29FO6 |
|
|
|
| GC18334-500mg |
|
51779-95-4 |
1,2-Dierucoyl-sn-glycero-3-PC
|
0 |
C52H100NO8P |
|
|
|
| GC18334-250mg |
|
51779-95-4 |
1,2-Dierucoyl-sn-glycero-3-PC
|
0 |
C52H100NO8P |
|
|
|
| GC18334-100mg |
|
51779-95-4 |
1,2-Dierucoyl-sn-glycero-3-PC
|
0 |
C52H100NO8P |
|
|
|
| GC18334-50mg |
|
51779-95-4 |
1,2-Dierucoyl-sn-glycero-3-PC
|
0 |
C52H100NO8P |
|
|
|
| GC18333-1mg |
|
517-09-9 |
|
0 |
C18H18O2 |
|
|
|
| GC18333-500μg |
|
517-09-9 |
|
0 |
C18H18O2 |
|
|
|
| GC18332-1g |
|
50-10-2 |
|
0 |
C21H34NO3.Br |
|
|
|
| GC18332-500mg |
|
50-10-2 |
|
0 |
C21H34NO3.Br |
|
|
|
| GC18332-100mg |
|
50-10-2 |
|
0 |
C21H34NO3.Br |
|
|
|
| GC18331-25mg |
|
74345-23-6, 4549-02-4 |
|
0 |
C14H16N2O3 |
|
|
|
| GC18331-5mg |
|
74345-23-6, 4549-02-4 |
|
0 |
C14H16N2O3 |
|
|
|
| GC18330-1g |
|
439108-20-0 |
3-Pyrimidin-2-yl-Propionic Acid
|
0 |
C7H8N2O2 |
|
|
|
| GC18330-500mg |
|
439108-20-0 |
3-Pyrimidin-2-yl-Propionic Acid
|
0 |
C7H8N2O2 |
|
|
|
| GC18330-100mg |
|
439108-20-0 |
3-Pyrimidin-2-yl-Propionic Acid
|
0 |
C7H8N2O2 |
|
|
|
| GC18330-50mg |
|
439108-20-0 |
3-Pyrimidin-2-yl-Propionic Acid
|
0 |
C7H8N2O2 |
|
|
|
| GC18328-25mg |
|
383907-87-7 |
|
0 |
C39H79N2O6P (for palmitoyl) |
|
|
|
| GC18328-5mg |
|
383907-87-7 |
|
0 |
C39H79N2O6P (for palmitoyl) |
|
|
|
| GC18327-1g |
|
3778-76-5 |
Todralazine (hydrochloride)
|
0 |
C11H12N4O2.HCl |
|
|
|
| GC18327-500mg |
|
3778-76-5 |
Todralazine (hydrochloride)
|
0 |
C11H12N4O2.HCl |
|
|
|
